Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder

This extrapolation analysis qualitatively compared the efficacy and safety profile of atomoxetine from Lilly clinical trial data in 6-7-year-old patients with attention-deficit/hyperactivity disorder (ADHD) with that of published literature in 4-5-year-old patients with ADHD (two open-label [4-5-yea...

Full description

Saved in:
Bibliographic Details
Published inJournal of child and adolescent psychopharmacology Vol. 25; no. 10; pp. 799 - 809
Main Authors Upadhyaya, Himanshu, Kratochvil, Christopher, Ghuman, Jaswinder, Camporeale, Angelo, Lipsius, Sarah, D'Souza, Deborah, Tanaka, Yoko
Format Journal Article
LanguageEnglish
Published United States Mary Ann Liebert, Inc 01.12.2015
Subjects
Online AccessGet full text

Cover

Loading…